Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer
Phase 1
40 Years
90 Years
40 Years
90 Years
Not Enrolling
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer
Inclusion Criteria:
- patients that did not underwent surgery
Exclusion Criteria:
- patients that underwent surgery
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Authority:
Portugal: Ministry of Health
Study ID:
ACCRC10
NCT ID:
NCT01456923
Start Date:
Completion Date:
Related Keywords:
- Colorectal Cancer
- DNA damaging agents
- Colorectal Neoplasms
Name | Location |
|---|
